Adaptimmune Therapeutics PLC (ADAP) Common Stock, Shares Authorized 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Adaptimmune Therapeutics PLC quarterly Common Stock, Shares Authorized history and growth rate from 2014 to 2024.
  • Adaptimmune Therapeutics PLC Common Stock, Shares Authorized for the quarter ending March 31, 2024 was 1.7 B shares, a 32.7% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 1.7 B +420 M +32.7% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.7 B +420 M +32.7% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 1.7 B +420 M +32.7% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 1.7 B +420 M +32.7% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 1.28 B +41.9 M +3.38% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 1.28 B +41.9 M +3.38% Dec 31, 2022 10-K 2024-03-06
Q3 2022 1.28 B +41.9 M +3.38% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 1.28 B +41.9 M +3.38% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 1.24 B +203 M +19.5% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 1.24 B +203 M +19.5% Dec 31, 2021 10-K 2023-03-06
Q3 2021 1.24 B +203 M +19.5% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 1.24 B +203 M +19.5% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 1.04 B +252 M +32.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 1.04 B +252 M +32.1% Dec 31, 2020 10-K 2022-03-14
Q3 2020 1.04 B +252 M +32.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 1.04 B +252 M +32.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 786 M +84.8 M +12.1% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 786 M +84.8 M +12.1% Dec 31, 2019 10-K 2021-02-25
Q3 2019 786 M +84.8 M +12.1% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 786 M +84.8 M +12.1% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 701 M 0 0% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 701 M 0 0% Dec 31, 2018 10-K 2020-02-27
Q3 2018 701 M 0 0% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 701 M 0 0% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 701 M +126 M +22% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 701 M +126 M +22% Dec 31, 2017 10-K 2019-02-27
Q3 2017 701 M +126 M +22% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 701 M +126 M +22% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 575 M 0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 575 M 0 0% Dec 31, 2016 10-K 2018-03-15
Q3 2016 575 M Sep 30, 2016 10-Q 2016-11-10
Q2 2016 575 M 0 0% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 575 M Mar 31, 2016 10-Q 2016-05-12
Q4 2015 575 M Dec 31, 2015 10-K 2017-03-13
Q2 2015 575 M +364 M +172% Jun 30, 2015 10-K 2017-03-13
Q2 2014 211 M Jun 30, 2014 8-K 2016-07-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.